Pacific Biosciences of California Inc. logo

Pacific Biosciences of California Inc.

PACB | NASDAQ
Chart Builder DCF Calculator
$1.36
-$0.01 (-0.73%)
At close: Sep 21, 2026, 4:00 PM ET
$1.37
+$0.01 (+0.74%)
Pre-market: Sep 22, 2026, 6:48 AM ET

Market Data

Market Cap
$425.52M
Enterprise Value
$1.07B
Beta
2.31
Average Volume
6.49M
Shares Outstanding (Diluted)
310.66M
Shares Change YoY
3.5%
Institutional Ownership
61.54%
Exchange
NASDAQ
ISIN
US69404D1081

Price Performance

Price Change 1M
0.7%
Price Change 3M
3.8%
Price Change 6M
-2.2%
Price Change YTD
-26.1%
Price Change 1Y
5.4%
Price Change 3Y
-84.8%
Price Change 5Y
-94.7%
1M CAGR (ann.)
17.1%
1Y CAGR (ann.)
11.4%
5Y CAGR (ann.)
-46.0%
All-Time CAGR
-14.5%

Valuation

PE Ratio
-3.16
Forward PE
N/A
PEG Ratio
-0.05
Forward PEG
2.73
PS Ratio
2.65
Forward PS
2.30
PB Ratio
-12.72
P/FCF Ratio
-2.47
P/Adj. FCF Ratio
-2.17
P/OCF Ratio
-2.62
EV/Sales
6.70
EV/EBIT
-8.43
EV/EBITDA
-9.40
EV/FCF
-6.24
Earnings Yield
-31.6%
FCF Yield
-40.5%
Adj. FCF Yield
-46.0%

Financial Health

Net Debt
$645.12M
Total Debt
$706.13M
Cash & Short-Term Investments
$61M
Total Assets
$751.85M
Current Ratio
4.92
Quick Ratio
4.03
Debt / Equity Ratio
-21.26
Debt / EBITDA
-6.22
Debt / FCF
-4.13
OCF / Debt
-0.23
Interest Coverage
-42.23
Altman Z-Score
-4.71
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
36.0%
Operating Profit Margin
-102.0%
EBITDA Margin
-68.5%
Net Profit Margin
-82.5%
FCF Margin
-107.5%
Adj. FCF Margin
-122.1%
SBC / Revenue
14.6%
SBC Impact (per share)
-13.6%

Returns

Return on Assets
-17.5%
Return on Equity
-4961.7%
Return on Invested Capital
-23.8%
Return on Capital Employed
-23.8%
Return on Tangible Assets
-31.2%

Historical Growth (CAGR)

Revenue CAGR 3Y
2.9%
Revenue CAGR 5Y
8.5%
Revenue CAGR 10Y
5.9%
EPS CAGR 3Y
43.1%
EPS CAGR 5Y
4.6%
EPS CAGR 10Y
-6.8%
FCF CAGR 3Y
22.9%
FCF CAGR 5Y
10.5%
FCF CAGR 10Y
-15.1%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
18
EPS Growth Next 3Y
13.2%
Revenue Growth Next 3Y
15.0%
Earnings Date
Nov 2, 2026
EPS Estimate (next Q)
-$0.13
EPS Growth Est (next Q)
5.0%
Revenue Est (next Q)
$43.82M
Revenue Growth Est (next Q)
14.0%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$1.18
Price Target Upside
-13.2%

Cash Flow

Operating Cash Flow
$-162.74M
Free Cash Flow
$-171.16M
Adj. Free Cash Flow
$-194.47M
FCF Per Share
-$0.55
OCF Per Share
-$0.52
OCF/S Ratio
-102.2%

Income Statement

Revenue
$159.27M
Gross Profit
$57.3M
Operating Income
$-162.54M
EBITDA
$-113.6M
Net Income
$-131.39M
EPS (Diluted)
-$0.43
Revenue / Employee
$328.39K
Profit / Employee
$-270.9K
Employees
485

© 2026 bestshares.com. All rights reserved.